Horga Maria Arantxa
SEC insider (Form 3/4/5 filer). CIK 0001829614. Chief Medical Officer at Atea Pharmaceuticals, Inc. (AVIR). 6 reported Form 4/5 transactions since Sep 2024; latest on Jan 31, 2026. Located in BOSTON, MA.
Companies Horga Maria Arantxa has filed insider reports for
- Atea Pharmaceuticals, Inc. (AVIR): Officer, Chief Medical Officer
Horga Maria Arantxa
CIK: 0001829614
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Atea Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jan 31, 2026AVIR
Atea Pharmaceuticals, Inc.
ExerciseDirect51.3K shares- - Jan 31, 2026AVIR
Atea Pharmaceuticals, Inc.
Tax PaymentDirect16.1K shares at avg. $4.24$68K - Jan 31, 2026AVIR
Atea Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
173.5K shares- - Jan 31, 2025AVIR
Atea Pharmaceuticals, Inc.
ExerciseDirect41.5K shares- - Jan 31, 2025AVIR
Atea Pharmaceuticals, Inc.
AwardDirect9.8K shares- - Jan 31, 2025AVIR
Atea Pharmaceuticals, Inc.
Tax PaymentDirect16.1K shares at avg. $3.06$49K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 31, 2026 | AVIR Atea Pharmaceuticals, Inc. | Exercise | 51,283 | - | $0 | Direct |
| Jan 31, 2026 | AVIR Atea Pharmaceuticals, Inc. | Tax Payment | 16,073 | $4.24 | $68,150 | Direct |
| Jan 31, 2026 | AVIR Atea Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 173,500 | - | - | Direct |
| Jan 31, 2025 | AVIR Atea Pharmaceuticals, Inc. | Exercise | 41,533 | - | - | Direct |
| Jan 31, 2025 | AVIR Atea Pharmaceuticals, Inc. | Award | 9,750 | - | - | Direct |
| Jan 31, 2025 | AVIR Atea Pharmaceuticals, Inc. | Tax Payment | 16,071 | $3.06 | $49,177 | Direct |
1-6 of 6 transactions